Patricio Morales

The ubiquitin‐proteasome system (UPS) is fundamental for the development and differentiation of male mammalian germ cells. As a key pathway for protein degradation, the UPS maintains cellular homeostasis by removing misfolded, damaged, or excess proteins, thus enabling cells to adapt to physiological and environmental changes. In male reproduction, the UPS regulates critical processes from spermatogenesis to the functionality of mature spermatozoa. During spermatogenesis in seminiferous tubules, the UPS orchestrates cell cycle regulation, apoptosis, and chromatin remodeling, ensuring that only the most viable germ cells differentiate. In the epididymis, the UPS facilitates sperm maturation, granting motility and functional characteristics. In addition, the UPS is essential for sperm capacitation in the female reproductive tract, which is a process critical for fertilization. Dysregulation of the UPS can severely impair male fertility and contribute to infertility and other reproductive disorders. This review provides a detailed examination of the role of the UPS in spermatogenesis, sperm maturation in the epididymis, and capacitation in the female reproductive tract. By exploring the molecular mechanisms underlying these processes, we highlight the clinical implications of UPS dysfunction and offer a comprehensive understanding of its contribution to mammalian reproductive success.

Previously, we reported that mating induces an early transcriptional response in the oviductal mucosa of rats. The functional category ‘cell-to-cell signaling and interaction’ was overrepresented in this gene list. Therefore, in the present study, we describe the role of one of these genes, carbohydrate sulfotransferase 10 (Chst10), in the oviductal mucosa. CHST10 participates in the synthesis of the carbohydrate moiety human natural killer-1 (HNK-1), which mediates cell-to-cell interactions. When using one-dimensional Western blot and sulfotransferase analyses, we found that mating increased the protein level and activity of CHST10 in the oviductal mucosa at 3 h after stimulation. A two-dimensional Western blot analysis and mass spectrometry were used to identify the novel HNK-1 glycoproteins aldehyde dehydrogenase 9 family, member A1 (ALDH9A1), fructose bisphosphate aldolase A (ALDOA), and four and a half LIM domains protein 1 (FHL1) in the oviductal mucosa, and we found that mating induces the synthesis of their acidic variants. Interestingly, in the utero-tubal junction (UTJ), acrosome-reacted sperm apparently were interacting with regions in which ALDH9A1 and HNK-1 signals overlap. Furthermore, vaginocervical stimulation applied to unmated rats increased the mRNA level of Chst10 in the oviductal mucosa. In conclusion, mating increases the activity of CHST10 in the oviductal mucosa, which in turn induces the synthesis of acidic variants of ALDH9A1 and FHL1 via HNK-1 glycosylation. ALDH9A1, HNK-1-ALDH9A1, and/or other HNK-1 glycoproteins could participate in the negative selection of sperm in the UTJ, since we detected acrosome-reacted sperm apparently interacting with regions where these proteins are located. Finally, the sensorial component of mating could regulate early events (e.g., sperm transport and selection) occurring in the oviductal mucosa after mating.

Previously, we reported that mating induces an early transcriptional response in the oviductal mucosa of rats. The functional category ‘cell-to-cell signaling and interaction’ was overrepresented in this gene list. Therefore, in the present study, we describe the role of one of these genes, carbohydrate sulfotransferase 10 (Chst10), in the oviductal mucosa. CHST10 participates in the synthesis of the carbohydrate moiety HNK-1, which mediates cell-to-cell interactions. Using 1D western blot and sulfotransferase assays, we showed that mating increased the protein level and activity of CHST10 in the oviductal mucosa at 3 h after stimulation. A 2D western blot assay and mass spectrometry were used to identify the novel HNK-1 glycoproteins ALDH9A1, ALDOA and FHL1 in the oviductal mucosa, and we showed that mating induces the synthesis of their acidic variants. Interestingly, in the utero-tubal junction (UTJ), acrosome-reacted sperm are in close contact with HNK-1-ALDH9A1 regions, and acrosome-intact sperm are in close contact with other regions in which HNK-1 and ALDH9A1 do not colocalize. Furthermore, vaginocervical stimulation applied to unmated rats increases the mRNA level of Chst10 in the oviductal mucosa. In conclusion, mating increases the activity of CHST10 in the oviductal mucosa, which in turn induces the synthesis of acidic variants of ALDH9A1 and FHL1 via HNK-1 glycosylation. In the UTJ, HNK-1-ALDH9A1 can control the quality of the sperm arriving at the fertilization site, since we detected acrosome-reacted sperm in close contact with this glycoprotein, a finding that merits further research to propose the use of HNK-1-ALDH9A1 in the selection of sperm in procedures of assisted reproduction. Finally, the sensorial component of mating could regulate events occurring in the oviductal mucosa early after mating.

Proteasome-mediated protein degradation is essential for maintaining cellular homeostasis, particularly during spermatogenesis, where extensive cellular transformations, such as spermatid differentiation, require precise protein turnover. A key player in this process is the ubiquitin–proteasome system (UPS). This study aimed to investigate proteasome enzymatic activity at different stages of the spermatogenic cycle within the seminiferous tubules of mice and explore the regulatory mechanisms that influence its proteolytic function. Specifically, we assessed the trypsin-like, chymotrypsin-like, and peptidyl-glutamyl-peptide-hydrolyzing (PGPH) activities of the proteasome. Additionally, we examined the expression of catalytic and structural subunits of the 20S core, the assembly of the 20S core with regulatory complexes, and the phosphorylation status of proteasome subunits in various segments of the seminiferous tubules. Our findings demonstrated distinct patterns of proteasomal enzymatic activity in the analyzed segments. While the expression levels of structural and catalytic subunits of the 20S core remained consistent, significant differences were detected in the assembly of the 20S core, the expression of regulatory complexes, and the phosphorylation of proteasome subunits mediated by protein kinase A. These results indicate that proteasomal activity is finely regulated through multiple mechanisms depending on the specific stage of the seminiferous epithelial cycle, highlighting the complexity of proteostasis during spermatogenesis.

Preclinical research has provided compelling evidence indicating that exposure to hypobaric hypoxia (HH) results in a deterioration of spermatogenesis. This adverse effect extends to the underlying molecular mechanisms, progressively leading to impairments in the seminiferous epithelium and germ cells and alterations in semen parameters. Indeed, several studies have demonstrated that animals exposed to HH, whether in natural high-altitude environments or under simulated hypoxic conditions, exhibit damage to the self-renewal and differentiation of spermatogenesis, an increase in germline cell apoptosis, and structural alterations in the seminiferous tubules. One of the primary mechanisms associated with the inhibition of differentiation and an increase in apoptosis among germ cells is an elevated level of oxidative stress, which has been closely associated with HH exposure. Human studies have shown that individuals exposed to HH, such as mountaineers and alpinists, exhibit decreased sperm count, reduced motility, diminished viability, and increased sperm with abnormal morphology in their semen. This evidence strongly suggests that exposure to HH may be considered a significant risk factor that could elevate the prevalence of male infertility. This literature review aims to provide a comprehensive description and propose potential mechanisms that could elucidate the infertility processes induced by HH. By doing so, it contributes to expanding our understanding of the challenges posed by extreme environments on human physiology, opening new avenues for research in this field.

The proteasome increases its activity at the onset of sperm capacitation due to the action of the SACY/PRKACA pathway; this increase is required for capacitation to progress. PRKA activity also increases and remains high during capacitation. However, intracellular levels of cAMP decrease in this process. Our goal was to evaluate the role of the proteasome in regulating PRKA activity once capacitation has started. Viable human sperm were incubated in the presence and absence of epoxomicin or with 0.1% DMSO. The activity of PRKA; the phosphorylation pattern of PRKA substrates (pPRKAs); and the expression of PRKAR1, PRKAR2, and AKAP3 were evaluated by Western blot. The localization of pPRKAs, PRKAR1, PRKAR2, and AKAP3 was evaluated by immunofluorescence. Treatment with epoxomicin changed the localization and phosphorylation pattern and decreased the percentage of pPRKAs-positive sperm. PRKA activity significantly increased at 1 min of capacitation and remained high throughout the incubation. However, epoxomicin treatment significantly decreased PRKA activity after 30 min. In addition, PRKAR1 and AKAP3 were degraded by the proteasome but with a different temporal kinetic. Our results suggest that PRKAR1 is the target of PRKA regulation by the proteasome.

One of the first events of mammalian sperm capacitation is the activation of the soluble adenyl cyclase/cAMP/protein kinase A (SACY/cAMP/PKA) pathway. Here, we evaluated whether the increase in PKA activity at the onset of human sperm capacitation is responsible for the activation of the sperm proteasome and whether this activation is required for capacitation progress. Viable human sperm were incubated with inhibitors of the SACY/cAMP/PKA pathway. The chymotrypsin-like activity of the sperm proteasome was evaluated using a fluorogenic substrate. Sperm capacitation status was evaluated using the chlortetracycline assay and tyrosine phosphorylation. To determine whether proteasomal subunits were phosphorylated by PKA, the proteasome was immunoprecipitated and tested on a western blot using an antibody against phosphorylated PKA substrates. Immunofluorescence microscopy analysis and co-immunoprecipitation (IPP) were used to investigate an association between the catalytic subunit alpha of PKA (PKA-Cα) and the proteasome. The chymotrypsin-like activity of the sperm proteasome significantly increased after 5 min of capacitation (P < 0.001) and remained high for the remaining incubation time. Treatment with H89, KT5720 or KH7 significantly decreased the chymotrypsin-like activity of the proteasome (P < 0.001). IPP experiments indicated that PKA inhibition significantly modified phosphorylation of proteasome subunits. In addition, PKA-Cα colocalized with the proteasome in the equatorial segment and in the connecting piece, and co-immunoprecipitated with the proteasome. This is the first demonstration of sperm proteasome activity being directly regulated by SACY/PKA-Cα. This novel discovery extends our current knowledge of sperm physiology and may be used to manage sperm capacitation during assisted reproductive technology procedures.

Fibronectin (Fn) enhances human sperm capacitation via the cAMP/PKA pathway, and the endocannabinoid system participates in this process. Moreover, Fn has been linked to endocannabinoid system components in different cellular models, even though no evidence of such interactions in human sperm is available. Normal semen samples were evaluated over a 4‐year period. Our findings suggest that (a) the capacitating effects of Fn were reversed by preincubating the sperm with a cannabinoid receptor 1 (CB1) or transient receptor potential cation channel subfamily V member 1 (TRPV1) antagonist ( p < 0.001 and p < 0.05, respectively); (b) cooperation between CB1 and TRPV1 may exist ( p < 0.01); (c) the activity of specific fatty acid amide hydroxylase (FAAH) decreased after 1 min ( p < 0.01) and increased after 60 min ( p < 0.01) of capacitation in the presence of Fn; (d) the effects of Fn on FAAH activity were prevented by preincubating spermatozoa with a protein kinase A (PKA) inhibitor ( p < 0.01); (e) Fn modulated both the cyclic adenosine monophosphate concentration and PKA activity ( p < 0.05) during early capacitation; and (f) FAAH was a PKA substrate modulated by phosphorylation. These findings indicate that Fn stimulates human sperm capacitation via the cAMP/PKA pathway through modulation of the endocannabinoid system. Understanding the functional competence of human spermatozoa is essential for facilitating clinical advances in infertility treatment and for developing novel contraceptive strategies.

Summary: In human spermatozoa, protein kinases have a role in the acrosome reaction (AR) induced by a variety of stimuli. However, there is disagreement or a lack of information regarding the role of protein kinases and phosphatases in the progesterone (P)‐induced increase in intracellular calcium concentration ([Ca²⁺]_i). In addition, there are no studies regarding the role of Ser/Thr and Tyr phosphatases and there are contradictory results regarding the role of Tyr kinases in the P‐induced acrosome reaction. Here, we performed a simultaneous evaluation of the involvement of protein kinases and phosphatases in the P‐induced acrosome reaction and in the P‐induced calcium influx. Motile spermatozoa were capacitated for 18 h and different aliquots were allocated to treated or control groups and then evaluated for their ability to undergo the acrosome reaction and to increase [Ca²⁺]_i in response to P. The acrosome reaction was evaluated using Pisum sativum agglutinin (PSA)‐FITC, and [Ca²⁺]_i was evaluated using fura 2AM. At all of the concentrations tested, PKA inhibitors significantly reduced the percentage of the P‐induced acrosome reaction (p < 0.001). However, only the highest concentrations of PKA inhibitors reduced the P‐induced calcium influx; lower concentrations of PKA inhibitors did not affect it. Similar results were apparent for PKC inhibitors and for tyrosine kinase inhibitors. None of the Ser/Thr phosphatase inhibitors affected the P‐induced acrosome reaction or the P‐induced calcium influx, except for the PP2B inhibitors that significantly reduced the P‐induced acrosome reaction without affecting calcium influx. Finally, the protein tyrosine phosphatase inhibitors significantly blocked the P‐induced acrosome reaction and reduced the amplitude of the P‐induced calcium transient (p < 0.001) as well as the amplitude of the plateau phase (p < 0.01). The data suggest that protein kinases and possibly PP2B have a role on the acrosome reaction at some point downstream of calcium entry and that Tyr phosphatases have a role on the acrosome reaction upstream of calcium entry.

There are few reports on the role of protein phosphatases during capacitation. Here, we report on the role of PP2B, PP1, and PP2A during human sperm capacitation. Motile sperm were resuspended in non-capacitating medium (NCM, Tyrode's medium, albumin- and bicarbonate-free) or in reconstituted medium (RCM, NCM plus 2.6% albumin/25 mM bicarbonate). The presence of the phosphatases was evaluated by western blotting and the subcellular localization by indirect immunofluorescence. The function of these phosphatases was analyzed by incubating the sperm with specific inhibitors: okadaic acid, I2, endothall, and deltamethrin. Different aliquots were incubated in the following media: 1) NCM; 2) NCM plus inhibitors; 3) RCM; and 4) RCM plus inhibitors. The percent capacitated sperm and phosphatase activities were evaluated using the chlortetracycline assay and a phosphatase assay kit, respectively. The results confirm the presence of PP2B and PP1 in human sperm. We also report the presence of PP2A, specifically, the catalytic subunit and the regulatory subunits PR65 and B. PP2B and PP2A were present in the tail, neck, and postacrosomal region, and PP1 was present in the postacrosomal region, neck, middle, and principal piece of human sperm. Treatment with phosphatase inhibitors rapidly (≤1 min) increased the percent of sperm depicting the pattern B, reaching a maximum of ∼40% that was maintained throughout incubation; after 3 h, the percent of capacitated sperm was similar to that of the control. The enzymatic activity of the phosphatases decreased during capacitation without changes in their expression. The pattern of phosphorylation on threonine residues showed a sharp increase upon treatment with the inhibitors. In conclusion, human sperm express PP1, PP2B, and PP2A, and the activity of these phosphatases decreases during capacitation. This decline in phosphatase activities and the subsequent increase in threonine phosphorylation may be an important requirement for the success of sperm capacitation.